Skip to main content

FDA criticized for tracking scientists' e-mails

The New York Times has reported that the Food and Drug Administration has engaged in widespread monitoring of e-mails from FDA scientists who had been critical of the agency's approval of certain medical devices. According to the article, "What began as a narrow investigation into the possible leaking of confidential agency information by five scientists quickly grew in mid-2010 into a much broader campaign to counter outside critics of the agency's medical review process, according to the cache of more than 80,000 pages of computer documents generated by the surveillance effort." Members of Congress from both parties were "irate to learn that correspondence between the scientists and their own staff had been gathered and analyzed."

An earlier Policy Alert issue (Feb. 1, 2012) reported on a lawsuit filed by six FDA employees concerning the agency's surveillance.

Related Links:  

Blog Name